Yupa Watchanakit / Shutterstock.com
US biotechnology company BioMarin Pharmaceutical has agreed to settle its patent infringement lawsuit against Dr Reddy’s Laboratories centring on its Kuvan (sapropterin dihydrochloride) drug.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
BioMarin, Dr. Reddy’s Laboratories, Kuvan, patent